Related references
Note: Only part of the references are listed.Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin
S. Goswami et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
Kaixin Zhou et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
S. L. Stocker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2013)
Linkage disequilibrium between the CYP2C19*17 allele and other clinically important CYP2C allelic variants in a healthy Scandinavian population
Rasmus Steen Pedersen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
Linda Tarasova et al.
PHARMACOGENETICS AND GENOMICS (2012)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
A Common 5′-UTR Variant in MATE2-K Is Associated With Poor Response to Metformin
J. H. Choi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
X. Stephenne et al.
DIABETOLOGIA (2011)
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2011)
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
Matthijs L. Becker et al.
PHARMACOGENETICS AND GENOMICS (2010)
Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms
Henriette E. Meyer Zu Schwabedissen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Expression of Organic Cation Transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) Is Affected by Genetic Factors and Cholestasis in Human Liver
Anne T. Nies et al.
HEPATOLOGY (2009)
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin
Ying Chen et al.
PHARMACOGENETICS AND GENOMICS (2009)
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
M. L. Becker et al.
PHARMACOGENOMICS JOURNAL (2009)
Genetic Variants of the Organic Cation Transporter 2 Influence the Disposition of Metformin
I. S. Song et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
Zhi-Jun Wang et al.
PHARMACOGENETICS AND GENOMICS (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1
Moto Kajiwara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine
Mingyan Zhou et al.
DRUG METABOLISM AND DISPOSITION (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
Eriko Shikata et al.
JOURNAL OF HUMAN GENETICS (2007)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4α
M Saborowski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
J Müller et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-α and -γ
WX Nie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis
GU Denk et al.
HEPATOLOGY (2004)
The SLC22 drug transporter family
H Koepsell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Polyspecific organic cation transporters: their functions and interactions with drugs
H Koepsell
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1 rOAT3 and rOCT2
Y Habu et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Reduced tubular cation transport in diabetes: Prevented by ACE inhibition
MC Thomas et al.
KIDNEY INTERNATIONAL (2003)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Mechanism by which metformin reduces glucose production in type 2 diabetes
RS Hundal et al.
DIABETES (2000)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
